The global lung cancer market is expected to witness significant growth in the coming years, driven by several factors such as the rising incidence of lung cancer, increasing awareness about the disease, and the availability of innovative treatments. According to a new report, the market is projected to grow at a CAGR of 13.5% during the forecast period from 2021 to 2028.
Lung cancer is the leading cause of cancer-related deaths worldwide. The increasing incidence of lung cancer is one of the major factors driving the growth of the lung cancer market. Smoking is one of the primary causes of lung cancer, and the prevalence of smoking in several countries is increasing. In addition, exposure to environmental factors such as pollution and secondhand smoke is also contributing to the rising incidence of lung cancer.
Another key driver of the lung cancer market is the increasing awareness about the disease. Governments and healthcare organizations are taking initiatives to raise awareness about lung cancer and its risk factors. This has led to increased screening and diagnosis of the disease, which has in turn led to increased demand for treatments.
Innovative treatments such as immunotherapy and targeted therapy are also driving the growth of the lung cancer market. These treatments are designed to target specific molecular abnormalities in cancer cells and have been found to be more effective and less toxic than traditional chemotherapy. In addition, liquid biopsy, a non-invasive diagnostic technique, is gaining popularity in the diagnosis and treatment of lung cancer.
The Asia-Pacific region is expected to be the fastest-growing market for lung cancer treatment during the forecast period. This can be attributed to the increasing incidence of lung cancer in the region, particularly in China and India. The availability of innovative treatments and the growing healthcare infrastructure in the region are also contributing to the growth of the market.
In conclusion, the global lung cancer market is poised for significant growth in the coming years. Factors such as the rising incidence of lung cancer, increasing awareness about the disease, and the availability of innovative treatments are driving the growth of the market. The Asia-Pacific region is expected to be the fastest-growing market for lung cancer treatment, and companies operating in the market are expected to focus on expanding their presence in the region to capitalize on the growing demand for treatments.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.